Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

01 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Mesoblast Ltd (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

30 Sep 2016 Thomson Reuters Stock Report 11 $25.00

ValuEngine Rating and Forecast Report for MESO

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

25 Sep 2016 ValuEngine, Inc. 11 $25.00

MESOBLAST LTD (MESO=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

24 Sep 2016 Pechala's Reports 2 $25.00

Mesoblast limited: Downgraded to Risky

13 Sep 2016 Sadif Analytics Prime 3 $10.00

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review Summary Mesoblast Limited (Mesoblast) is a regenerativ...

06 Sep 2016 GlobalData 65 $300.00

Wright Investors Service Comprehensive Report for Mesoblast Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 Sep 2016 Wright Reports 64 $75.00

Mesoblast Limited - Mesoblast Appoints Bill Burns, Former Chief Executive of Roche Pharmaceuticals, as Vice Chairman

01 Sep 2016 irasia.com 2 $23.00

Mesoblast Limited (ASX- MSB; Nasdaq- MESO)

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Th...

26 Aug 2016 Acquisdata 17 $15.00